<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-41059" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Case Study: 8-Year-Old With a Murmur and Hypertension (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>John</surname>
            <given-names>Alan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bring</surname>
            <given-names>Katie</given-names>
          </name>
          <aff>University of Creighton School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Van Horn</surname>
            <given-names>Ngoc L.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alan John declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Katie Bring declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ngoc Van Horn declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-41059.s1" sec-type="Case Presentation">
        <title>Case Presentation</title>
        <p content-type="pubmed-excerpt">An 8-year-old female presents to the emergency&#x000a0;department (ED) referred by her primary care provider (PCP) for left-sided neck swelling and murmur. Per the patient&#x02019;s mother, the patient has had left-sided neck swelling for 1 month. The patient also experienced subjective fevers, chills, headaches, and malaise. Over that same period, mom also noticed about 5 pounds (2 kg) of weight loss and intermittent side pain.&#x000a0;Because of these concerns, mom took her daughter to the PCP&#x000a0;2 weeks before ED presentation and was diagnosed with lymphadenitis and started on oral amoxicillin-clavulanic acid and told to follow up the following week. At the following visit, there was a minimal improvement of the neck swelling, so the patient was switched to oral clindamycin.&#x000a0;After a week of being on the clindamycin, the patient presented again to the PCP with minimal improvement of her symptoms. At this visit, the PCP also noticed a new cardiac murmur. Because the patient had failed outpatient antibiotic therapy and had this new heart murmur, the PCP referred the patient to the ED.</p>
      </sec>
      <sec id="article-41059.s2" sec-type="Initial Evaluation">
        <title>Initial Evaluation</title>
        <p>On arrival to the ED, the patient had appropriate vital signs for her age other than a blood pressure of 169/96. On physical exam, the patient was noted to have a&#x000a0;grade 2/6 systolic heart murmur without evidence of radiation. She denies any symptoms of lightheadedness, syncope, palpitations, or fatigue with exertion. Mom states that the patient never had any heart problems nor was there significant family history. The other significant findings on the physical exam were a firm, yet mobile 2-cm mass slightly superior to the left anterior cervical lymphatic chain as well as a weak left radial and brachial pulse.</p>
      </sec>
      <sec id="article-41059.s3" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis includes, but is not limited to:</p>
        <p>
<italic toggle="yes">
<bold>Cardiovascular</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Aneurysm</p>
          </list-item>
          <list-item>
            <p>Arterial-vascular malformation</p>
          </list-item>
          <list-item>
            <p>Atherosclerosis</p>
          </list-item>
          <list-item>
            <p>Fibromuscular dysplasia</p>
          </list-item>
          <list-item>
            <p>Giant cell arteritis</p>
          </list-item>
          <list-item>
            <p>Infectious aortitis</p>
          </list-item>
          <list-item>
            <p>Takayasu arteritis</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Infectious Disease</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Abscess</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Cat scratch disease</p>
          </list-item>
          <list-item>
            <p>Ebstein Barr virus/mononucleosis (EBV)</p>
          </list-item>
          <list-item>
            <p>Human immunodeficiency virus (HIV)</p>
          </list-item>
          <list-item>
            <p>Lymphadenitis</p>
          </list-item>
          <list-item>
            <p>Mycobacterium/Tuberculosis (TB)</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">
<bold>Hematology/Oncology</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Leukemia</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Immunologic/Lymphatic</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Branchial cleft cyst</p>
          </list-item>
          <list-item>
            <p>Dermoid cyst</p>
          </list-item>
          <list-item>
            <p>Fibroma</p>
          </list-item>
          <list-item>
            <p>Kawasaki</p>
          </list-item>
          <list-item>
            <p>Salivary gland cyst</p>
          </list-item>
          <list-item>
            <p>Thyroglossal duct cyst</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41059.s4" sec-type="Confirmatory Evaluation">
        <title>Confirmatory Evaluation</title>
        <p>Lab workup included:</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood culture</p>
          </list-item>
          <list-item>
            <p>Complete blood count</p>
          </list-item>
          <list-item>
            <p>Comprehensive metabolic profile</p>
          </list-item>
          <list-item>
            <p>Inflammatory markers (Erythrocyte sedimentation rate (ESR), C-reactive protein [CRP])</p>
          </list-item>
          <list-item>
            <p>Ebstein Barr panel/monospot</p>
          </list-item>
          <list-item>
            <p>Streptococcal throat swab</p>
          </list-item>
        </list>
        <p>Laboratory testing including HIV, EBV, TB, blood, urine, and throat cultures was all negative.</p>
        <p>ESR and CRP were elevated at 72 and 11.7. Blood count was unremarkable and metabolic panel was notable for hypokalemia to 3.1.</p>
        <p>Diagnostic imaging included:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chest x-ray</p>
          </list-item>
          <list-item>
            <p>Echocardiography (ECHO)</p>
          </list-item>
          <list-item>
            <p>Electrocardiogram</p>
          </list-item>
          <list-item>
            <p>Magnetic Resonance Imaging and Arteriogram (MRI/MRA)</p>
          </list-item>
          <list-item>
            <p>Ultrasound of the neck and soft tissue</p>
          </list-item>
        </list>
        <p>Ultrasound of neck showed wall thickening of the left common carotid artery with possible involvement of the left internal carotid artery.</p>
        <p>The ECHO was notable for a bicuspid aortic valve, as well as a mildly dilated left ventricle with mildly decreased left ventricular function.</p>
        <p>MRI/MRA revealed large vessel vasculitis involving the left external carotid artery, left renal artery, superior mesenteric artery, and left subclavian artery.</p>
      </sec>
      <sec id="article-41059.s5" sec-type="Diagnosis">
        <title>Diagnosis</title>
        <p>With the combination of hypertension, a dilated left ventricle, and multiple areas of vasculitis, the diagnosis of Takayasu arteritis was made. The neck mass was likely secondary to vasculitis involving the left carotid artery. Given the physical exam findings, elevated inflammatory markers, multiple cardiac findings, and hypertension, cardiology was consulted, and the patient was admitted.<xref ref-type="bibr" rid="article-41059.r1">[1]</xref><xref ref-type="bibr" rid="article-41059.r2">[2]</xref><xref ref-type="bibr" rid="article-41059.r3">[3]</xref></p>
      </sec>
      <sec id="article-41059.s6" sec-type="Management">
        <title>Management</title>
        <p>In the ED, nifedipine was given once for hypertension, and her blood pressure responded appropriately. The patient also had a 4/5 headache that was treated with acetaminophen and ibuprofen, and it improved. Nephrology was consulted. The specialist recommended a renal ultrasound and other labs as well as starting amlodipine 5 mg daily. The patient was admitted to the hospital for further management.<xref ref-type="bibr" rid="article-41059.r4">[4]</xref><xref ref-type="bibr" rid="article-41059.r5">[5]</xref><xref ref-type="bibr" rid="article-41059.r6">[6]</xref></p>
        <p>The patient was started on nifedipine (calcium channel blocker, anti-hypertensive) for her hypertension and then ultimately discharged on carvedilol. Furthermore, for coagulation prophylaxis, she was started on low-dose aspirin due to arteritis involving the left common carotid and vertebral artery.</p>
        <p>Rheumatology was also consulted and recommended to start low-dose steroids and mycophenolic acid to help decrease the amount of arterial inflammation.</p>
        <p>Nephrology was also consulted in conjunction with cardiology for blood pressure management. In addition to starting anti-hypertensive medications, she was placed on daily fluid restriction.</p>
      </sec>
      <sec id="article-41059.s7" sec-type="Discussion">
        <title>Discussion</title>
        <p>Takayasu arteritis is a condition in which pathogenesis is poorly understood. It is believed that pathological infiltration of inflammatory cells in the aorta and its different luminal layers and branches are the underlying mechanisms for this disease. This inflammatory process eventually leads to dilation, occlusion, or stenosis of the affected vessel, which can all present in a variety of clinical manifestations.<xref ref-type="bibr" rid="article-41059.r7">[7]</xref></p>
        <p>Takayasu arteritis is a chronic disease with many episodes of exacerbations and remissions of the inflammatory processes. Adult women are primarily affected as they represent 80% to 90% of cases. This disease onset is between 10 to 40 years old, and the diagnosis of Takayasu arteritis tends to be delayed due to the sub-acute onset of symptoms in this disease. This can sometimes lead to worsening progression of disease in this asymptomatic period.</p>
        <p>Since the pathophysiology can affect the vessels in different ways, patients can present with a wide array of clinical symptoms. Non-specific findings such as fever, fatigue, and malaise can be the only symptoms present early in the course of this disease. Other common signs and symptoms include weak peripheral pulses, hypertension, limb claudication, gastrointestinal (GI) symptoms, and murmurs.</p>
        <list list-type="bullet">
          <list-item>
            <p>Physical exam: Physical exam should include careful examination of peripheral pulses and cardiac auscultation. Blood pressure reading in all extremities can also be used as a tool to help aid in diagnosis.</p>
          </list-item>
          <list-item>
            <p>Laboratory: This condition is largely an inflammatory process so inflammatory markers such as ESR and CRP should be obtained. However, these values can still be within the normal range and not reliable in the detection of the active disease process.</p>
          </list-item>
          <list-item>
            <p>Diagnostic imaging: Imaging of the aorta is needed to determine the extent of damage to the aorta. Computerized tomography (CT) of the chest or MRI can be used to detect patency of the aortic lumen.</p>
          </list-item>
        </list>
        <p>Histology shows infiltration of predominantly lymphocytes, histiocytes, macrophages, and plasma cells in the media of the aorta and its branches. Progressive damage and destruction of the lamina and media can lead to aneurysmal dilation or dense scarring.</p>
        <p>The mainstay of treatment for this condition is steroids. Steroids suppress the progression of the disease and can sometimes reverse early complications. Surgery is an option for patients with aneurysms or severe stenosis. The patient can eventually be weaned off of steroids with symptom and inflammatory marker improvement.</p>
      </sec>
      <sec id="article-41059.s8" sec-type="Pearls of Wisdom">
        <title>Pearls of Wisdom</title>
        <list list-type="bullet">
          <list-item>
            <p>Recognize age-appropriate vital signs.</p>
          </list-item>
          <list-item>
            <p>Do a thorough physical exam especially with patients who have failed outpatient management.</p>
          </list-item>
          <list-item>
            <p>Takayasu arteritis is often misdiagnosed and therefore not properly treated. It is important to recognize early signs of this disease and provide&#x000a0;work-up and reassessment&#x000a0;accordingly.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41059.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=41059&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=41059">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/41059/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=41059">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-41059.s10">
        <title>References</title>
        <ref id="article-41059.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Artery Involvement in Patients with Takayasu Arteritis.</article-title>
            <source>J Rheumatol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-272</page-range>
            <pub-id pub-id-type="pmid">31092716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sathish Kumar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Danda</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy.</article-title>
            <source>Paediatr Drugs</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-93</page-range>
            <pub-id pub-id-type="pmid">31087279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yonezawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Izawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hayakari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asakura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Taniguchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Isa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yasumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishikomori</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Takita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report.</article-title>
            <source>J Pharm Health Care Sci</source>
            <year>2019</year>
            <volume>5</volume>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">31073411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Calanca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Borgeat Kaeser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mazzolai</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature.</article-title>
            <source>Eur Heart J Case Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>yty123</fpage>
            <pub-id pub-id-type="pmid">31020199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novikov</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Zykova</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Moiseev</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>The modern therapy of systemic vasculitides: perspectives and challenges.</article-title>
            <source>Ter Arkh</source>
            <year>2018</year>
            <month>Feb</month>
            <day>14</day>
            <volume>90</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-85</page-range>
            <pub-id pub-id-type="pmid">30701763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Wakhlu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Danda</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in the management of Takayasu arteritis.</article-title>
            <source>Int J Rheum Dis</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>22 Suppl 1</volume>
            <fpage>60</fpage>
            <page-range>60-68</page-range>
            <pub-id pub-id-type="pmid">30698358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41059.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dejaco</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Update on the epidemiology, risk factors, and outcomes of systemic vasculitides.</article-title>
            <source>Best Pract Res Clin Rheumatol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-294</page-range>
            <pub-id pub-id-type="pmid">30527432</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
